
The European Commission is “ready to guide” companies and lawyers on acceptable cooperation agreements during the coronavirus pandemic.
The Directorate-General for Competition yesterday established a new webpage entitled “antitrust rules and coronavirus,” which outlines policies and antitrust measures in the wake of the coronavirus outbreak.
The aim is to help businesses design temporary cooperation arrangements in a pro-competitive way to help Europe overcome the coronavirus crisis in a united manner, the commission said.
DG Comp also created an email address where companies and lawyers can ask for “informal guidance” on specific cases. The commission received questions regarding the coronavirus crisis from stakeholders before it set up the mailbox.
The authority is “ready to guide companies, associations and their legal advisors” if there is “uncertainty” about whether certain conduct is compatible with competition law, DG Comp said on its webpage.
This applies for cooperation that needs to be “swiftly” implemented to tackle the coronavirus pandemic, it said.
The “exceptional circumstances” mean companies may need to cooperate with each other to overcome the crisis, the commission said, for instance to ensure that there is an available supply and fair distribution of essential scarce products and services for consumers.
It added that it is “more important than ever that businesses and consumers receive protection under competition law”. The authority will continue to monitor relevant market developments to detect companies that take advantage of the pandemic to breach EU antitrust law, it said.
Last week, the European Competition Network – which includes the European Commission and national competition authorities in EU member states – said that it would not intervene in necessary and temporary cooperation between companies to deal with the coronavirus pandemic.
Richard Pepper, a counsel at Cleary Gottlieb Steen & Hamilton, said that so far the European guidance has been rather “light-touch,” as it largely replicates the pre-existing framework for assessing cooperation.
“A lot of practitioners are now anticipating a broader discussion on whether those principles are fit for purpose… or whether the commission will explicitly broaden its tolerance levels in the short term”, he said.
He added he hopes the commission’s antitrust staff will be able to process requests as quickly as their state aid colleagues have dealt with the “flurry of applications.”
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas